Advancing biologics requires confidence in safety, quality, and compliance. Learn how integrated analytical and biosafety testing, backed by decades of expertise, helps reduce risk.
Discover how in‑house NGS and robust data management streamline CQA analysis, reduce risk, and strengthen development workflows from early research through manufacturing.
Digital transformation drives agility and compliance in drug manufacturing. Optimize your processes, improve quality control, and accelerate time-to-market without adding operational friction.
A dual approach to nucleic acid removal and residual nuclease detection simplifies impurity control, enhances consistency, and maintains compliance across high-salt GMP processes.
Gain real-time visibility across facility equipment. Cloud-based monitoring and continuous performance checks prevent downtime while supporting full FDA 21 CFR Part 11 requirements.
Explore practical guidance, technical tools, and specialized support to simplify your documentation workflow, reduce submission friction, and keep your regulatory approvals moving forward.
Transform your cell and gene pipeline with targeted development support. Access technical insights and practical strategies designed to take your therapy from early concept to clinical success.
Automated, closed systems simplify media production for CGTs. Streamline formulation and fill processes while maintaining strict GMP standards and protecting product integrity.
Leveraging an established platform process provides a path to GMP manufacturing, simplified regulatory documentation, process validation, and a clear route toward commercial production.
